These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
518 related articles for article (PubMed ID: 24036273)
1. Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities. Kirtane AR; Kalscheuer SM; Panyam J Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1731-47. PubMed ID: 24036273 [TBL] [Abstract][Full Text] [Related]
2. Role of integrated cancer nanomedicine in overcoming drug resistance. Iyer AK; Singh A; Ganta S; Amiji MM Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506 [TBL] [Abstract][Full Text] [Related]
3. Reversal of multidrug resistance by the inhibition of ATP-binding cassette pumps employing "Generally Recognized As Safe" (GRAS) nanopharmaceuticals: A review. Sosnik A Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1828-51. PubMed ID: 24055628 [TBL] [Abstract][Full Text] [Related]
4. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors. Dallavalle S; Dobričić V; Lazzarato L; Gazzano E; Machuqueiro M; Pajeva I; Tsakovska I; Zidar N; Fruttero R Drug Resist Updat; 2020 May; 50():100682. PubMed ID: 32087558 [TBL] [Abstract][Full Text] [Related]
5. Nanopreparations to overcome multidrug resistance in cancer. Patel NR; Pattni BS; Abouzeid AH; Torchilin VP Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1748-62. PubMed ID: 23973912 [TBL] [Abstract][Full Text] [Related]
6. Overcoming drug efflux-based multidrug resistance in cancer with nanotechnology. Xue X; Liang XJ Chin J Cancer; 2012 Feb; 31(2):100-9. PubMed ID: 22237039 [TBL] [Abstract][Full Text] [Related]
7. ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development. Choi YH; Yu AM Curr Pharm Des; 2014; 20(5):793-807. PubMed ID: 23688078 [TBL] [Abstract][Full Text] [Related]
8. Nanomedicine therapeutic approaches to overcome cancer drug resistance. Markman JL; Rekechenetskiy A; Holler E; Ljubimova JY Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1866-79. PubMed ID: 24120656 [TBL] [Abstract][Full Text] [Related]
9. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function. Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385 [TBL] [Abstract][Full Text] [Related]
10. Reversion of Multidrug Resistance by Co-Encapsulation of Doxorubicin and Metformin in Poly(lactide-co-glycolide)-d-α-tocopheryl Polyethylene Glycol 1000 Succinate Nanoparticles. Shafiei-Irannejad V; Samadi N; Salehi R; Yousefi B; Rahimi M; Akbarzadeh A; Zarghami N Pharm Res; 2018 Apr; 35(6):119. PubMed ID: 29671072 [TBL] [Abstract][Full Text] [Related]
11. A Sequentially Responsive Nanosystem Breaches Cascaded Bio-barriers and Suppresses P-Glycoprotein Function for Reversing Cancer Drug Resistance. Liu J; Zhao L; Shi L; Yuan Y; Fu D; Ye Z; Li Q; Deng Y; Liu X; Lv Q; Cheng Y; Xu Y; Jiang X; Wang G; Wang L; Wang Z ACS Appl Mater Interfaces; 2020 Dec; 12(49):54343-54355. PubMed ID: 32959645 [TBL] [Abstract][Full Text] [Related]
12. Recent advances in drug delivery systems for targeting cancer stem cells. Duan H; Liu Y; Gao Z; Huang W Acta Pharm Sin B; 2021 Jan; 11(1):55-70. PubMed ID: 33532180 [TBL] [Abstract][Full Text] [Related]
13. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes. To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522 [TBL] [Abstract][Full Text] [Related]
15. Tackling multidrug resistance mediated by efflux transporters in tumor-initiating cells. McIntosh K; Balch C; Tiwari AK Expert Opin Drug Metab Toxicol; 2016 Jun; 12(6):633-44. PubMed ID: 27116192 [TBL] [Abstract][Full Text] [Related]
16. Folic Acid-Modified Nanoerythrocyte for Codelivery of Paclitaxel and Tariquidar to Overcome Breast Cancer Multidrug Resistance. Zhong P; Chen X; Guo R; Chen X; Chen Z; Wei C; Li Y; Wang W; Zhou Y; Qin L Mol Pharm; 2020 Apr; 17(4):1114-1126. PubMed ID: 32176509 [TBL] [Abstract][Full Text] [Related]
17. Alpha-tocopheryl polyethylene glycol succinate-emulsified poly(lactic-co-glycolic acid) nanoparticles for reversal of multidrug resistance in vitro. Wang Y; Guo M; Lu Y; Ding LY; Ron WT; Liu YQ; Song FF; Yu SQ Nanotechnology; 2012 Dec; 23(49):495103. PubMed ID: 23149859 [TBL] [Abstract][Full Text] [Related]
18. The basic and clinical implications of ABC transporters, Y-box-binding protein-1 (YB-1) and angiogenesis-related factors in human malignancies. Kuwano M; Uchiumi T; Hayakawa H; Ono M; Wada M; Izumi H; Kohno K Cancer Sci; 2003 Jan; 94(1):9-14. PubMed ID: 12708467 [TBL] [Abstract][Full Text] [Related]
19. Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters. Fan YF; Zhang W; Zeng L; Lei ZN; Cai CY; Gupta P; Yang DH; Cui Q; Qin ZD; Chen ZS; Trombetta LD Cancer Lett; 2018 May; 421():186-198. PubMed ID: 29331420 [TBL] [Abstract][Full Text] [Related]
20. Multi-modal strategies for overcoming tumor drug resistance: hypoxia, the Warburg effect, stem cells, and multifunctional nanotechnology. Milane L; Ganesh S; Shah S; Duan ZF; Amiji M J Control Release; 2011 Oct; 155(2):237-47. PubMed ID: 21497176 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]